14th Annual PEGS Boston

April 30 - May 4, 2018
Boston, USA

Oliver Hill, Ph.D., VP Molecular Biology
Karl Heinonen, M.Sc., Laboratory Head of Protein Production

Presentation by Oliver Hill, Ph.D.: May 4, 9:05 am EDT
"HERA: Engineering Next Generation TNFR-SF Agonists for Cancer Immunotherapy"


CIMT 2018 Annual Meeting

15. - 17. Mai 2018
Mainz, Germany

Viola Marschall, Ph.D., Senior Scientist Assay Development
Matthias Schröder, Ph.D., Senior Scientist Assay Development
Julian Sefrin, Ph.D., Senior Scientist Immunology

Poster Presentations:
Anticancer immunity mediated by the novel hexavalent human GITR agonist HERA-GITRL is conveyed by activating T cells without affecting Treg cells
(Dr. Marschall)
HERA-LIGHT, a novel hexavalent HVEM agonist promoting T cell activation and expansion (Dr. Sefrin)